Back to today’s briefing

Story perspectives

CellProthera's Stem Cells Aim to Revolutionize Heart Recovery

5/30/2025

37 7

Summary

Story summary

CellProthera is on a mission to heal hearts with ProtheraCytes, innovative stem cells derived from patients' own CD34+ cells. By focusing on the right patients and prompt treatment, they aim to revolutionize recovery after heart attacks. A pivotal Phase 3 trial in the USA and Europe will measure ProtheraCytes against standard care, while challenges like sourcing quality donor cells loom, as highlighted by Dr. Ibon Garitaonandia.

1 of 1

Story summary

CellProthera is on a mission to heal hearts with ProtheraCytes, innovative stem cells derived from patients' own CD34+ cells. By focusing on the right patients and prompt treatment, they aim to revolutionize recovery after heart attacks. A pivotal Phase 3 trial in the USA and Europe will measure ProtheraCytes against standard care, while challenges like sourcing quality donor cells loom, as highlighted by Dr. Ibon Garitaonandia.